GetTopicDetailResponse(id=baf1114805aa, topicName=IBI310, introduction=, content=黑色素瘤 尿路上皮癌 信迪利單抗 IBI310, image=null, comments=0, allHits=917, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri May 24 09:30:48 CST 2024, time=2024-05-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=491036, tagList=[TagDto(tagId=491036, tagName=IBI310)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2206375, encodeId=560922063e542, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a> <a href='/topic/show?id=c3aa4e516d6' target=_blank style='color:#2F92EE;'>#尿路上皮癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利單抗#</a> <a href='/topic/show?id=baf1114805aa' target=_blank style='color:#2F92EE;'>#IBI310#</a>, objectTitle=The innovation：IBI310(抗CTLA-4抗體)單藥或聯(lián)合信迪利單抗治療晚期黑色素瘤或尿路上皮癌的I期研究, objectType=article, longId=827222, objectId=7be982e222b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240524/1716514226108_92910.png, objectUrl=/article/show_article.do?id=7be982e222b2, replyNumber=0, likeNumber=164, createdTime=2024-05-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7be982e222b2, moduleTitle=The innovation：IBI310(抗CTLA-4抗體)單藥或聯(lián)合信迪利單抗治療晚期黑色素瘤或尿路上皮癌的I期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7be982e222b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-05-24發(fā)表于上海
